503 related articles for article (PubMed ID: 10335000)
1. Randomised trial of an inhaled beta2 agonist, inhaled corticosteroid and their combination in the treatment of asthma.
Hancox RJ; Cowan JO; Flannery EM; Herbison GP; McLachlan CR; Wong CS; Taylor DR
Thorax; 1999 Jun; 54(6):482-7. PubMed ID: 10335000
[TBL] [Abstract][Full Text] [Related]
2. Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment.
Hancox RJ; Cowan JO; Flannery EM; Herbison GP; McLachlan CR; Taylor DR
Respir Med; 2000 Aug; 94(8):767-71. PubMed ID: 10955752
[TBL] [Abstract][Full Text] [Related]
3. Effects of terbutaline and budesonide on sputum cells and bronchial hyperresponsiveness in asthma.
Aldridge RE; Hancox RJ; Robin Taylor D; Cowan JO; Winn MC; Frampton CM; Town GI
Am J Respir Crit Care Med; 2000 May; 161(5):1459-64. PubMed ID: 10806139
[TBL] [Abstract][Full Text] [Related]
4. Effects of inhaled beta agonist and corticosteroid treatment on nuclear transcription factors in bronchial mucosa in asthma.
Hancox RJ; Stevens DA; Adcock IM; Barnes PJ; Taylor DR
Thorax; 1999 Jun; 54(6):488-92. PubMed ID: 10335001
[TBL] [Abstract][Full Text] [Related]
5. Effect of regular terbutaline on the airway response to inhaled budesonide.
Wilding PJ; Clark MM; Oborne J; Bennett JA; Tattersfield AE
Thorax; 1996 Oct; 51(10):989-92. PubMed ID: 8977598
[TBL] [Abstract][Full Text] [Related]
6. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
de Jong JW; van der Mark TW; Koëter GH; Postma DS
Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
[TBL] [Abstract][Full Text] [Related]
7. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.
Pauwels RA; Löfdahl CG; Postma DS; Tattersfield AE; O'Byrne P; Barnes PJ; Ullman A
N Engl J Med; 1997 Nov; 337(20):1405-11. PubMed ID: 9358137
[TBL] [Abstract][Full Text] [Related]
8. Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial.
Wechsler ME; Kunselman SJ; Chinchilli VM; Bleecker E; Boushey HA; Calhoun WJ; Ameredes BT; Castro M; Craig TJ; Denlinger L; Fahy JV; Jarjour N; Kazani S; Kim S; Kraft M; Lazarus SC; Lemanske RF; Markezich A; Martin RJ; Permaul P; Peters SP; Ramsdell J; Sorkness CA; Sutherland ER; Szefler SJ; Walter MJ; Wasserman SI; Israel E;
Lancet; 2009 Nov; 374(9703):1754-64. PubMed ID: 19932356
[TBL] [Abstract][Full Text] [Related]
9. Early asthma control and maintenance with eformoterol following reduction of inhaled corticosteroid dose.
Price D; Dutchman D; Mawson A; Bodalia B; Duggan S; Todd P;
Thorax; 2002 Sep; 57(9):791-8. PubMed ID: 12200524
[TBL] [Abstract][Full Text] [Related]
10. Maximal response plateau to methacholine as a reliable index for reducing inhaled budesonide in moderate asthma.
Prieto L; Gutiérrez V; Morales C
Eur Respir J; 1999 Jun; 13(6):1236-44. PubMed ID: 10445596
[TBL] [Abstract][Full Text] [Related]
11. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study.
Rabe KF; Atienza T; Magyar P; Larsson P; Jorup C; Lalloo UG
Lancet; 2006 Aug; 368(9537):744-53. PubMed ID: 16935685
[TBL] [Abstract][Full Text] [Related]
12. Effect of an inhaled glucocorticosteroid on mast cell and smooth muscle beta 2 adrenergic tolerance in mild asthma.
Yates DH; Worsdell M; Barnes PJ
Thorax; 1998 Feb; 53(2):110-3. PubMed ID: 9624295
[TBL] [Abstract][Full Text] [Related]
13. Comparison of high and low dose of the inhaled steroid, budesonide, as an initial treatment in newly detected asthma.
Tukiainen H; Taivainen A; Majander R; Poussa T; Svahn T; Puolijoki H; Terho EO
Respir Med; 2000 Jul; 94(7):678-83. PubMed ID: 10926339
[TBL] [Abstract][Full Text] [Related]
14. Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years.
Tattersfield AE; Town GI; Johnell O; Picado C; Aubier M; Braillon P; Karlström R
Thorax; 2001 Apr; 56(4):272-8. PubMed ID: 11254817
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial.
Laitinen LA; Laitinen A; Haahtela T
J Allergy Clin Immunol; 1992 Jul; 90(1):32-42. PubMed ID: 1629507
[TBL] [Abstract][Full Text] [Related]
16. Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency department: a randomized controlled trial.
Rowe BH; Bota GW; Fabris L; Therrien SA; Milner RA; Jacono J
JAMA; 1999 Jun; 281(22):2119-26. PubMed ID: 10367823
[TBL] [Abstract][Full Text] [Related]
17. Comparison of oral bambuterol and inhaled salmeterol in patients with symptomatic asthma and using inhaled corticosteroids.
Crompton GK; Ayres JG; Basran G; Schiraldi G; Brusasco V; Eivindson A; Jamieson AH; Olsson H
Am J Respir Crit Care Med; 1999 Mar; 159(3):824-8. PubMed ID: 10051257
[TBL] [Abstract][Full Text] [Related]
18. A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma.
Evans DJ; Taylor DA; Zetterstrom O; Chung KF; O'Connor BJ; Barnes PJ
N Engl J Med; 1997 Nov; 337(20):1412-8. PubMed ID: 9358138
[TBL] [Abstract][Full Text] [Related]
19. Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial.
Papi A; Marku B; Scichilone N; Maestrelli P; Paggiaro P; Saetta M; Nava S; Folletti I; Bertorelli G; Bertacco S; Contoli M; Plebani M; Barbaro MPF; Spanevello A; Aliani M; Pannacci M; Morelli P; Beghé B; Fabbri LM;
Lancet Respir Med; 2015 Feb; 3(2):109-119. PubMed ID: 25481378
[TBL] [Abstract][Full Text] [Related]
20. Budesonide and terbutaline or terbutaline alone in children with mild asthma: effects on bronchial hyperresponsiveness and diurnal variation in peak flow.
Waalkens HJ; Gerritsen J; Koëter GH; Krouwels FH; van Aalderen WM; Knol K
Thorax; 1991 Jul; 46(7):499-503. PubMed ID: 1877037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
